Theranostics World Congress

Discover the Highlights of TWC2024! 🎬 We’re excited to share with you the first trailer highlighting the key moments and insights from the 7th Theranostic World Congress (TWC) held in Santiago, Chile. 🌟 Mark your calendars for the next TWC! The 8th edition of our congress will take place from January 29 to February 1, 2026, in the vibrant city of Cape Town, South Africa. While the exact location is still being finalized, we promise an exciting program packed with the latest advancements and innovations in Theranostics. Stay tuned for more updates as we continue planning this landmark event. We look forward to seeing you there! 🔗 Watch the trailer here: https://lnkd.in/ec9FWn43 #TWC2026 #Theranostics #MedicalScience

📸 Reflecting on TWC 2024: A Journey in Pictures Two months ago, from March 22nd to 24th, 2024, we embarked on an unforgettable journey at the Theranostics World Congress (TWC). Today, let's take a moment to reminisce and celebrate the moments that made the congress truly remarkable. Join us as we revisit the vibrant atmosphere, engaging discussions, and unforgettable experiences captured in these images from the event. From enlightening sessions to networking opportunities, each picture tells a story of innovation, collaboration, and passion for advancing theranostics. 🌐 For a more comprehensive recap, visit the TWC website for an in-depth look at the highlights of TWC 2024: https://lnkd.in/e39CDGtG 👏 A heartfelt thank you to all the participants, sponsors, organizers, and service providers for making this event a tremendous success! 👉 Exciting news! The next TWC is anticipated to take place in Cape Town, South Africa, in December 2025. Stay tuned for updates! #TWC2024 #Theranostics #Throwback #Innovation #Networking 📊🔬

🏆 Celebrating Excellence: Recap of TWC2024 Award Winners After a rejuvenating break following TWC2024, it's time for a reflection on the outstanding achievements recognized at the congress. Here are the remarkable award winners: --- 🌟 Saul Hertz Young Investigator Award Named after the pioneer of targeted cancer therapies this award honors emerging talent in theranostics. Award Winner: Prof. Dr. Simone Krebs, Memorial Sloan Kettering Cancer Center, USA --- 🌟 Jorge Nicolini Young Investigator Award Named after the esteemed Dr. Jorge Nicolini, this award celebrates excellence in radiopharmacy and theranostics-related fields. Award Winner: Dr. Sara Rinne, PhD, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, USA --- 🌟 Edwaldo E. Camargo Young Investigator Award In memory of Dr. Edwaldo Eduardo Camargo, this award recognizes remarkable contributions to Nuclear Medicine and theranostics. Award Winner: Dr. Sanjala Ballal, Department of Nuclear Medicine at All India Institute of Medical Sciences, India --- 🌟 Best Abstract Awards Highlighting exceptional research in Radiomolecular Precision Medicine, these abstracts stood out among submissions. Award Winners: - Irma Soldevilla Gallardo, Mexico City, Mexico - Habibollah Dadgar, Mashhad, Iran - Sydney Jackson, USA --- Congratulations to all the deserving winners for their remarkable contributions to advancing the field of theranostics! Find more information at TWC2024 Awards Page: https://lnkd.in/egHiCnQ6 #TWC2024 #Theranostics #AwardWinners #MedicalResearch 🚀

On Saturday, I had the honor of sharing the stage with three very special thought leaders in Radioligand Therapy (RLT) at the 7th Theranostic World Congress in Santiago de Chile. During the Novartis fireside chat, they shared their thoughts on how partnerships can support innovation and the evolution of RLT. Prof Chandrasekhar Bal, Michael Hofman and Mike Sathekge, your ability to keep at the cutting edge of RLT is a present and future gift to patients worldwide with advanced cancers. We are grateful to the organizers Vasko Kramer and Horacio Amaral for the opportunity to host the session. Thank you to Richard P. Baum & Prof. Dr. Frank Rösch for their continued leadership of this conference. This session was only made possible by the collective talent in the RLT Healthcare Systems Readiness team at Novartis. Thank you Leonhard Schaetz, Jasminka Taleska, and in particular, Panagiota (Penny) Papaioannou for the leadership of the session. #worldtheranosticcongress #nuclearmedicine #rlt #radioligandtherapy #novartis

A few days ago, at Theranostics World Congress we had the pleasure to share time with Barbara Hertz, Dr. Hertz daughter, after our e-póster and oral presentation of our work with Cecilia Carreras Velázquez Francisco Osvaldo García-Perez Jorge Schalch at Hospital Angeles Health System about 131I Dosimetry in Thyroid Cancer. New paradigms and correlations between 131I administered activity - dosimetry - histology will come !! David Mirando MIM Software https://lnkd.in/erqEKSee

Theranostics World Congress Congratulations to KUKM team, theranostic experts and industry partners for a very successful Theranostic World Congress in Santiago de Chile. I felt honoured to address this august gathering on behalf of the radiopharmaceutical program of the IAEA. TWC brought together all the stakeholders - radiochemists, medical physicists, nuclear medicine physicians from industry, academia, institutions around the globe with a single aim to make more effective and safer theranostic products. Most important is to assure patient access from tens of thousands today to millions of patients around the globe. This is what we precisely try to do at the IAEA, through our various program activities and flagship initiatives to mitigate gaps in cancer care. It was a great opportunity to interact with TWC delegates. Looking forward to continued interactions and support to our activities that are crucial for offering latest developments in theranostics to more patients the world over. muchas gracias !! TWC!!

The 7th Theranostics World Congress has concluded and it has been like a dream come true. The Nuclear Medicine service of Hospital Ángeles Lomas Huixquilucan, Edo. México / Hospital Angeles Health System, actively participated in the presentation of a paper (oral and poster), together with Francisco Osvaldo García-Perez and Jorge Schalch, participation as moderator of Danny Mena Cortes and Cecilia Carreras Velázquez, as a panelist in the patient panel of Oncidium foundation and ICPO Foundation-International Centers for Precision Oncology. I am very grateful for everything I have experienced and learned, for the old friends and the new ones, for the achievements and projects to come. Big thanks to the organizers Prof. Richard P. Baum, Prof. Dr. Frank Rösch, Prof. Horacio Amaral and Prof. Vasko Kramer. 26 assistents from Mexico! 🇲🇽 Looking forward to attend the 8th Theranostics World Congress in South Africa. Agolti Mariela, Isabel Hume, Harshad Kulkarni, Barbara Hertz, Ralph Wirtz, Odile JAUME, Susanne Simon, Mike Sathekge, Michael Hofman, Carleton Whitmore, David Mirando, Cristiana Gameiro, Gilli Bader, Eyal Gimshi, Claudia Celaya Lujan, Arturo Quintanilla MD PhD, Andrea Falla Flórez, Oscar Porras, Melina Calderon, Rebecca Lo bue, Tala Allahham, Floriane Laurent, Alice Viana, Pierre Affaticati, Fernando Faccio, Moises Trujillo, Thank you! Hasta pronto!!!!!

TME Diagnostics and TME Therapeutics Session at the 7th Theranostics World Congress in Santiago de Chile March 22-24, 2024 A huge thank you to all the speakers who shared their expertise and groundbreaking research during our TME Diagnostics and TME Theranostics Sessions at the 7th Theranostics World Congress in Santiago de Chile. Your insights have illuminated new paths in cancer diagnostics and therapy, bringing hope for improved patient outcomes. We want to thank the Scientific Board and Organizing Committee of the TWC especially Dr. Horacio Amaral, Vasko Kramer, Richard P. Baum and Prof. Dr. Frank Rösch as well as the KUKM team around Brandon Bernack for the fantastic support setting up this marvelous congress in a country where we all want to come back. Chairs: TME Diagnostics Session Prof. Munir Ghesani, Mount Sinai Health System, USA), Chief of Nuclear Medicine at Mount Sinai Health and Prof. Andrew Scott, Director of the Department of Molecular Imaging and Therapy, at Austin Health, Heidelberg-Melbourne, Australia Speakers History and biology of FAP: implications for clinical use of new generation FAP-ligands, Prof. Andrew Scott (Department of Molecular Imaging And Therapy, Austin Health, Australia) Druglike, 18F-labeled PET tracers targeting fibroblast activation protein (FAP) Pieter Van Der Veken (University of Antwerp, Belgium) Overview of today’s clinical applications and perspectives Univ.-Prof. Dr. Frederik Giesel, MD, MBA (Heinrich Heine University Düsseldorf, Germany) Online FAPI – Advancements in diagnostics Sherly Mosessian Mossesian (Sofie Bioscience, USA) & Paul Evans (GEHC, USA) FAPI Diagnostics: clinical impact and future role of FAPI-PET Tadashi Watabe (Osaka University, Japan)   Chair TME Therapeutics Session Prof. Dr. med. Michael Kreissl Head of Nuclear Medicine at the University Clinic for Radiology and Nuclear Medicine in Magdeburg, Germany   Dr. Elisabeth Eppard Radiochemist at University Clinic of Magdeburg at the Department of Nuclear Medicine Speakers:   Clinical applications and perspectives of 3BP-3940 Prof. Richard P. Baum (Curanosticum Wiesbaden, Germany) FAPi-Dimers-Chemistry and preclinical evaluation Dr. Marcel Martin (TetraKit Technologies, Denmark) Assessing the long-term impact of FAP dimer therapy in cancer treatment sanjana ballal (AIIMS, India) Next generation 64Cu- and 225Ac-labelled radioligands for FAP-targeted therapy John Babich (Ratio Therapeutics, USA) Novel FAP-targeting small molecule radio-conjugates with high and prolonged tumour uptake Jacqueline Mock (Philochem, Switzerland) Online Radiotheranostics with Dual Targeting Probe 68Ga-/18F-/177Lu-FAPI-RGD in diverse solid tumors Jingjing Zhang (University of Singapore) #ICPOICPO Foundation-International Centers for Precision Oncology #OdileOdile JAUME, #SusanneSusanne Simon #Theranostics #Cancer #Treatment #Diagnostics #Radiotheranostics More info:

Last day at the Theranostics World Congress Very Interesting sessions this morning on the isotope production!

BLADDER CANCER BECOMES THERANOSTIC - happy to have had the opportunity to introduce bladder cancer and its underlying biology as new indication with so much positive feedback, new partners & friends across the globe from Mexico, Chile, South Africa ,Korea and China as well as new therapeutic ooportunities being identified for fast track evaluatiin in the RADIOMOLECULAR INCUBATOR. THANKS to everyone for this overwhelming feedback ! Greetings from the 7th theranostic World Congress in Santiago de Chile with more than 600 participants from all over the world - enabling a true change in cancer therapy across indications.